QBFM
NEO icon

QS Batterymarch Financial Management’s NeoGenomics NEO Stock Holding History

QS Batterymarch Financial Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,708
Closed -$29K – 926
2014
Q2 		$29K Buy
+8,708
New +$28.9K ﹤0.01% 791

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
GP
Grow Partners San Diego, California $4.81M AUM 7.86% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

QS Batterymarch Financial Management's NEO Position: Q3 2014 in Review

QS Batterymarch Financial Management sold out of NeoGenomics (NEO) in Q3 2014, closing a stake of 8,708 shares — an estimated $29K sold.

QS Batterymarch Financial Management first reported a position in NEO in Q2 2014 and held it in 1 quarter. The position peaked at $29K in Q2 2014. 88 funds tracked by Wall St. Rank hold NEO as of Q3 2014.

  • QS Batterymarch Financial Management reported no remaining NeoGenomics position as of Q3 2014 after selling out during the quarter.
  • QS Batterymarch Financial Management sold 8,708 NeoGenomics shares in Q3 2014, an estimated $29K.
  • QS Batterymarch Financial Management first reported a position in NeoGenomics in Q2 2014 and held it in 1 quarter.
  • QS Batterymarch Financial Management's NeoGenomics position peaked at $29K in Q2 2014.
  • 88 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.